Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

By The Numbers? Flawed Cholesterol Calculator May Boost Statins
Pharmalot
Monday, November 18, 2013 - 11:47am
tags:
cholesterol, statins
Titan Pharma Gets Solidified Commitment From Braeburn To Probuphine
Seeking Alpha
Monday, November 18, 2013 - 11:29am
tags:
Titan Pharmaceuticals, Braeburn Pharmaceuticals, Probuphine
TriVascular raises $40M Series E round
Mass Device
Monday, November 18, 2013 - 11:24am
tags:
TriVascular, devices, Ovation, stent grafts
Has Myeloma Met Its Match in Amgen's Kyprolis?
Motley Fool
Monday, November 18, 2013 - 11:07am
tags:
Multiple Myeloma, Amgen, Kyprolis, Celgene
Gilead’s Idelalisib Significantly Reduces Rate of Disease Progression or Death in Phase 3 Chronic Lymphocytic Leukemia Study
Yahoo
Monday, November 18, 2013 - 10:28am
tags:
Gilead, Idelalisib, CLL, chronic lymphocytic leukemia
Trevena IPO- Another Day Another Bio IPO
Seeking Alpha
Monday, November 18, 2013 - 10:14am
tags:
IPOs, Trevena
Medtronic guidewires draw Class I recall due to deadly risk
Fierce Medical Devices
Monday, November 18, 2013 - 10:07am
tags:
Medtronic, recalls, guidewires
Whither Sanofi R&D? Another Setback For An Oncology Drug
Pharmalot
Monday, November 18, 2013 - 10:05am
tags:
Sanofi, R&D, fedratinib, myelofibrosis
AbbVie steps closer to FDA filing as first hep C PhIII delivers promising results
Fierce Biotech
Monday, November 18, 2013 - 10:04am
tags:
sofosbuvir, FDA, AbbVie, hepatitis C
A Shifting Paradigm in Heart Disease Could Affect These Drugmakers
Motley Fool
Monday, November 18, 2013 - 10:01am
tags:
heart disease, Amgen, statins, Regeneron, Pfizer, Sanofi, PCSK9 inhibitors
Merck’s New Drug Application for an Investigational Intravenous (IV) Formulation of NOXAFIL® (posaconazole) Receives FDA Priority Review
Yahoo
Monday, November 18, 2013 - 9:59am
tags:
Merck, Noxafil, Aspergillus, Candida, FDA
Northwest Biotherapeutics Poses Onyx Like Potential
Seeking Alpha
Monday, November 18, 2013 - 9:56am
tags:
Northwest Biotherapeutics, Agenus, Celldex, ONYX Pharmaceuticals, ImmunoCellular Therapeutics
CareFusion to buy GE's respiratory, anesthesiology products business
Reuters
Monday, November 18, 2013 - 8:25am
tags:
General Electric, M&A, devices, CareFusion
What Does a Mixed FDA Verdict Mean for Sanofi's MS Drug?
Motley Fool
Monday, November 18, 2013 - 8:24am
tags:
FDA, Sanofi, MS, Lemtrada, multiple sclerosis
Princeton University Awaits Word on Meningitis Vaccine
Bloomberg
Monday, November 18, 2013 - 8:22am
tags:
meningitis, vaccine, Novartis
Could 2014 Bring A New Air To Celsion?
Seeking Alpha
Monday, November 18, 2013 - 8:20am
tags:
Celsion, ThermoDox
Johnson & Johnson Vs. Medivation In Prostate Cancer Race
Seeking Alpha
Monday, November 18, 2013 - 8:19am
tags:
JNJ, Medivation, prostate cancer, Xtandi, Astellas, Zytiga
Sun Pharma raises revenue growth guidance after spike in Q2 net profit
Financial Express
Sunday, November 17, 2013 - 12:22pm
tags:
Sun Pharma
Delivering on Promises Is Key for Isis
Daily Finance
Sunday, November 17, 2013 - 12:19pm
tags:
Isis Pharmaceuticals
Amarin, Sarepta And Vanda: Teachable Moments In Biotech
Seeking Alpha
Sunday, November 17, 2013 - 12:13pm
tags:
Amarin, Sarepta, Vanda

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.